BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34426610)

  • 21. Secretory carrier membrane proteins interact and regulate trafficking of the organellar (Na+,K+)/H+ exchanger NHE7.
    Lin PJ; Williams WP; Luu Y; Molday RS; Orlowski J; Numata M
    J Cell Sci; 2005 May; 118(Pt 9):1885-97. PubMed ID: 15840657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three mammalian SCAMPs (secretory carrier membrane proteins) are highly related products of distinct genes having similar subcellular distributions.
    Singleton DR; Wu TT; Castle JD
    J Cell Sci; 1997 Sep; 110 ( Pt 17)():2099-107. PubMed ID: 9378760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RepSox slows decay of CD34+ acute myeloid leukemia cells and decreases T cell immunoglobulin mucin-3 expression.
    Jajosky AN; Coad JE; Vos JA; Martin KH; Senft JR; Wenger SL; Gibson LF
    Stem Cells Transl Med; 2014 Jul; 3(7):836-48. PubMed ID: 24855276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic role of SCAMP family in acute myeloid leukemia.
    Qian T; Cheng Z; Quan L; Zeng T; Cui L; Liu Y; Si C; Huang W; Dai Y; Chen J; Liu L; Jiao Y; Deng C; Pang Y; Ye X; Shi J; Fu L
    Pharmacogenomics J; 2020 Aug; 20(4):595-600. PubMed ID: 31988488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of integrin α7 for acute myeloid leukemia risk and its correlation with prognosis in acute myeloid leukemia patients.
    Zeng M; Ding S; Zhang H; Huang Q; Ren Y; Guo P
    J Clin Lab Anal; 2020 Apr; 34(4):e23151. PubMed ID: 31855276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia.
    Lin MS; Zhong HY; Yim RL; Chen QY; Du HL; He HQ; Lin K; Zhao P; Gao R; Gao F; Zhang MY
    BMC Cancer; 2022 Oct; 22(1):1068. PubMed ID: 36243694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia.
    Xu X; Zhao Y; Xu M; Dai Q; Meng W; Yang J; Qin R
    Med Oncol; 2011 Dec; 28 Suppl 1():S483-9. PubMed ID: 20812035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miRNA-mRNA Profiling Reveals Prognostic Impact of
    Gadewal N; Kumar R; Aher S; Gardane A; Gaur T; Varma AK; Khattry N; Hasan SK
    Oncol Res; 2020 May; 28(3):321-330. PubMed ID: 32059753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic role of TPD52 in acute myeloid leukemia: A retrospective multicohort analysis.
    Ha M; Han ME; Kim JY; Jeong DC; Oh SO; Kim YH
    J Cell Biochem; 2019 Mar; 120(3):3672-3678. PubMed ID: 30203488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of RHOBTB2 aberration as an independent prognostic indicator in acute myeloid leukemia.
    Liu P; Ma Q; Chen H; Zhang L; Zhang X
    Aging (Albany NY); 2021 Jun; 13(11):15269-15284. PubMed ID: 34074803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia.
    Pan JQ; Zhang YQ; Wang JH; Xu P; Wang W
    Int J Mol Med; 2017 Mar; 39(3):663-671. PubMed ID: 28204819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SALL4 Gene Expression in Acute Myeloid Leukemia.
    Ibraheem FM; Badawy R; Ayoub MA; Hassan NM; Mostafa MN
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):3121-3127. PubMed ID: 31653163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secretory Carrier Membrane Protein 2 Regulates Cell-surface Targeting of Brain-enriched Na+/H+ Exchanger NHE5.
    Diering GH; Church J; Numata M
    J Biol Chem; 2009 May; 284(20):13892-13903. PubMed ID: 19276089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of purine-rich element binding protein B as a novel biomarker in acute myelogenous leukemia prognostication.
    Kelm RJ; Lamba GS; Levis JE; Holmes CE
    J Cell Biochem; 2018 Feb; 119(2):2073-2083. PubMed ID: 28834593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH
    BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The characteristics of circRNA as competing endogenous RNA in pathogenesis of acute myeloid leukemia.
    Zhang S
    BMC Cancer; 2021 Mar; 21(1):277. PubMed ID: 33722210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value and potential mechanism of long non-coding RNA Lnc-SMIM20-1 in acute myeloid leukemia.
    Liu S; Sun Z; Zhu M; Liu M; Wei M; Pan X; Huang S
    Expert Rev Anticancer Ther; 2022 Aug; 22(8):875-885. PubMed ID: 35894677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for colocalization and interaction between 37 and 39 kDa isoforms of secretory carrier membrane proteins (SCAMPs).
    Wu TT; Castle JD
    J Cell Sci; 1997 Jul; 110 ( Pt 13)():1533-41. PubMed ID: 9224770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
    Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
    J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pirin downregulation is a feature of AML and leads to impairment of terminal myeloid differentiation.
    Licciulli S; Cambiaghi V; Scafetta G; Gruszka AM; Alcalay M
    Leukemia; 2010 Feb; 24(2):429-37. PubMed ID: 20010624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.